IDXX

#328
Idexx Laboratories Inc
582.59 USD
+1.50%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
571.07
582.59
年范围
398.75
769.98
日变化
+1.50%
每月变动
-0.01%
6个月变化
-9.00%
年变化
+43.74%
前一天收盘价
574.00
开盘价
571.50
买价
卖价
最低价
571.07
High
582.59
交易量
70
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 46.39 B
  • Employee 11 K
  • Founded 1983
  • CEO Jay Mazelsky
  • Website www.idexx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLRT07
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
51.72
市销率
12.76

IDEXX Laboratories Inc

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.

新闻